Amilek sp. z o.o.
+ business areaCMO/CDMO/Biosimilars
+ annual revenue
2020 – 2,900,000 PLN
2021 – 3,000,000 PLN
2022 – 3,600,000 PLN
2023 – 4,400,000 PLN
+ workforce (estimated if not reported)
2024 - 28
+ depreciation & amortization
2020 – 49,400 PLN
2021 – 54,200 PLN
2022 – 60,000 PLN
2023 – 159,200 PLN
2024 – 179,900 PLN
Polish contract manufacturer of dietary supplements, operational since 2003, delivering high-quality supplements including capsules, tablets, powders, and natural vitamin preparations manufactured under EU standards.